IL6 and idiopathic pulmonary fibrosis: Hence, this study revealed potential interactions between immune infiltrates, diseased fibroblastic foci and alveolar septae in IPF that may downregulate inflammatory mechanisms (IL-6 activity) that inhibit fibrosis.